BBI Life Sciences Competitors and Similar CompaniesClear all
BBI Life Sciences's competitors and similar companies include AavantiBio, Cambium Bio, Canopy Biosciences and Elim Biopharm.
 AavantiBio AavantiBio is a biotechnology company dedicated to gene therapy research in the rare disease space. |  Cambium Bio Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology. |  Canopy Biosciences Canopy Biosciences is a life science company that provides research tools and services for genetic engineering, molecular biology, and personalized medicine. |  Elim Biopharm Elim Biopharmaceuticals is a life science service company for the biotech, pharmaceutical, and medical communities. | ||
Founding Date | Founding Date 2013 | Founding Date 2020 | Founding Date 2007 | Founding Date 2016 | Founding Date 1998 |
Type | Type Private | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations CN HQ | Locations Cambridge, US HQ | Locations Paddington, AU HQ Pymble, AU | Locations St. Louis, US HQ Leipzig, DE Hayward, US | Locations Hayward, US HQ |
Employees | Employees 1,588 | Employees 6 | Employees N/A | Employees 244% decrease | Employees 215% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥703.8m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) $670k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥288m (FY, 2019) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥417.2m (FY, 2019) | Gross profit N/A | Gross profit $1.2m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ¥86m (FY, 2019) | Net income N/A | Net income ($3.8m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 10.3m (over 11 years ago) | Latest funding round $ 107m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 2.4m (almost 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 10.3m | Total funding raised $ 107m | Total funding raised N/A | Total funding raised $ 4.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
AavantiBio
HQ
Cambridge, US
Employees
6
AavantiBio is a biotechnology company dedicated to gene therapy research in the rare disease space.
View companyCambium Bio
HQ
Paddington, AU
Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology.
View companyCanopy Biosciences
HQ
St. Louis, US
Employees
24↓ 4% decrease
Canopy Biosciences is a life science company that provides research tools and services for genetic engineering, molecular biology, and personalized medicine.
View companyElim Biopharm
HQ
Hayward, US
Employees
21↓ 5% decrease
Elim Biopharmaceuticals is a life science service company for the biotech, pharmaceutical, and medical communities.
View company